Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world.

CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term.

• The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of:
  • research questions that matter to patients, and
  • improved accrual
• CCTG is committed to implementing best practices and materials to foster and facilitate patient engagement

CCTG Patient Representatives

Judy Needham - Patient Representative Chair
Bob Taylor	Carol Gordon	David McMullen	Erwin Wanderer
Janice Hodgson	Joan Petrie	Jill Hamer-Wilson	Lynne Bezanson
Marie Therese Little	Martina Wood	Patrick Sullivan	Richard Wassersug
Robin Fried	Marg Redlick